0001493152-22-030702.txt : 20221104 0001493152-22-030702.hdr.sgml : 20221104 20221104165259 ACCESSION NUMBER: 0001493152-22-030702 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221104 DATE AS OF CHANGE: 20221104 EFFECTIVENESS DATE: 20221104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Biofrontera Inc. CENTRAL INDEX KEY: 0001858685 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473765675 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-463968 FILM NUMBER: 221362914 BUSINESS ADDRESS: STREET 1: 120 PRESIDENTIAL WAY, STREET 2: SUITE 330 CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: 781-245-1325 MAIL ADDRESS: STREET 1: 120 PRESIDENTIAL WAY, STREET 2: SUITE 330 CITY: WOBURN STATE: MA ZIP: 01801 D 1 primary_doc.xml X0708 D LIVE 0001858685 Biofrontera Inc. 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA MASSACHUSETTS 01801 781-245-1325 DELAWARE None None Corporation true John J III Borer 120 Presidential Way, Suite 330 Woburn MA MASSACHUSETTS 01801 Director Beth J Hoffman 120 Presidential Way, Suite 330 Woburn MA MASSACHUSETTS 01801 Director Hermann Luebbert 120 Presidential Way, Suite 330 Woburn MA MASSACHUSETTS 01801 Executive Officer Director Executive Chairman and Director of Biofrontera Inc. Kevin D Weber 120 Presidential Way, Suite 330 Woburn MA MASSACHUSETTS 01801 Director Loretta M Wedge 120 Presidential Way, Suite 330 Woburn MA MASSACHUSETTS 01801 Director Erica L Monaco 120 Presidential Way, Suite 330 Woburn MA MASSACHUSETTS 01801 Executive Officer Chief Executive Officer of Biofrontera Inc. Erica F Gates 120 Presidential Way, Suite 330 Woburn MA MASSACHUSETTS 01801 Executive Officer Senior Director Finance of Biofrontera Inc. Eugene Frederick Leffler 120 Presidential Way, Suite 330 Woburn MA MASSACHUSETTS 01801 Executive Officer Chief Financial Officer of Biofrontera Inc. Pharmaceuticals Decline to Disclose 06b false 2022-10-25 false true false 0 3683209 3683209 0 Reflects a privately negotiated exchange of 3,148,042 shares of Biofrontera Inc. common stock for an option to acquire 2,623,365 shares of Biofrontera AG. Offering amount based upon closing price of Biofrontera Inc. on 10/25/2022 ($1.17). true 1 1 0 0 0 false Biofrontera Inc. /s/ Erica Monaco Erica Monaco Chief Executive Officer 2022-11-04